what is the difference between semaglutide tirzepatide and retatrutide vs. vs. Semaglutide vs Tirzepatide vs Retatrutide:

Semaglutide, a GLP*1 receptor agonist, reduces appetite via GLP*1 receptors in the hypothalamus and increases the production, and reduces glucagon secretion, delaying gastric emptying

It is not a decision to be made lightly or without medical supervision

Ipamorelin is not FDA-approved as a prescription drug in the U.S., so product quality and labeling accuracy can be a major concern outside legitimate medical oversight

Novo Nordisk advanced amycretin, a GLP-1/amylin receptor agonist, straight to Phase 3 after early results showed weight reductions up to 24.3%

A meta-analysis of cardiovascular outcomes trials indicates that spontaneous medullary thyroid carcinomas have been diagnosed in patients receiving GLP-1RA (6 with active vs